News
11,238 News Articles
Mar
21
2025
Clinical practice evidence of treatment satisfaction with moderate and | PPA - Dove Medical Press
Introduction: Generally, the choice of disease-modifying treatment (DMT) for people with multiple sclerosis (PwMS) is based on aspects of efficacy and ...
Mar
21
2025
PharmAla Completes Shipment of LaNeo™ MDMA to the University of Washington
TORONTO, March 21, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology ...
MDMA
Mar
21
2025
(PDF) Safety and Efficacy of Repeated Low-Dose LSD for ADHD Treatment in Adults
PDF | Importance Microdosing psychedelics, including lysergic acid diethylamide (LSD), has gained attention for its potential benefits in several.
LSD
Mar
21
2025
Ketamine for unipolar major depression: critical examination of antidepressant effects
Abstract. This critical appraisal of a Cochrane Review assesses the efficacy of ketamine for treating unipolar major depressive disorder. The review ...
Mar
21
2025
Language creates an altered state of consciousness | Jeremy I Skipper - IAI TV
His lab uses psychedelic compounds to understand the interrelationship between the neurobiology of language, consciousness, and wellbeing. 3,256 words.
Mar
21
2025
Trending Report on Psychedelic Drugs Market 2025-2032 Business
Press release - CoherentMI - Trending Report on Psychedelic Drugs Market 2025-2032 Business Outlook, Critical Insight and Growth Strategy | Celon ...
Mar
21
2025
Contextual and experiential aspects of the psychedelic experience predicting improvement ...
Background: Interest in the therapeutic effects of classical psychedelics has risen recently. However, little epidemiological knowledge exists ...
Mar
21
2025
Analyzing Possible Industry Implications Of FDA Advisory Panel Decision On MDMA
About a week ago, an advisory committee to the U.S. Food and Drug Administration (FDA) rejected evidence supporting the approval of MDMA as an ...
MDMA
Mar
20
2025
The Austin Chronic: Crying at a SXSW Panel About Psychedelics
Having both researched and experienced the healing power of psychedelics, Robbins wants to see more culturally informed psychedelic-assisted therapy ...
Psychedelics
Mar
20
2025
Numinus Approved as a State-Certified Natural Medicine Training Program in Colorado
... psilocybin-assisted therapy in accordance with Colorado's regulations. ... Numinus' state-approved certification pathway includes coursework in ...
Mar
20
2025
The internet is convinced—Elon Musk is on ketamine. His quirky gestures and unpredictable ...
... Ketamine #SpaceX #Tesla #DOGE #Trump #Elon #Depression ... Ketamine #SpaceX #Tesla #DOGE #Trump #Elon #Depression #RecreationalDrugs ...
Ketamine
Mar
20
2025
Numinus Approved as a State-Certified Natural Medicine Training Program in Colorado
... psilocybin services by trained and licensed professionals. NUMIF) (CNW Group/Numinus Wellness Inc.)" alt="Numinus Wellness Inc. (TSX: NUMI, OTCQB ...
Mar
20
2025
Exploring Perceived Barriers and Facilitators for Implementing Acute Pain Clinical Trials
Exploring the barriers and facilitators to an inpatient clinical trial of ketamine infusion for treatment of acute sickle cell disease (SCD) pain.
Mar
20
2025
Bionic Bloom Expands Integrative Psychiatry Team
Addition of Arielle Bernhardt, MSN, APRN ST PETERSBURG, FL / ACCESS Newswire / March 19, 2025 / Bionic Bloom, the nation's first legal psilocybin ...
Mar
19
2025
LSD Microdosing Doesn't Appear to Help Treat Adult ADHD - Psychiatrist.com
... psychedelics that are likely prone to a placebo ... Psychedelics · Therapeutic Potential of Psychedelics in the Treatment of Psychiatric Disorders ...
Psychedelics
Mar
19
2025
Federal judge orders return of Utah religious group's psilocybin mushrooms
... psilocybin mushrooms. "Singularism is optimistic that through partnership and dialogue, it can foster an environment that respects diversity and ...
Mar
19
2025
Clearmind Medicine (CMND) to Evaluate Intranasal Delivery of Its Psychedelic Drug Combination
(Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the “Company”), a clinical-stage biotech company focused on discovery and development of novel psychedelic ...
Mar
19
2025
Psilocybin therapy demonstrates sustained clinical benefit in treatment-resistant depression
The new data shows potential of psilocybin to provide durable, longer-term antidepressant effects in patients with TR-depression.
Mar
19
2025
Clinical Features Associated With Response to Ketamine vs Electroconvulsive Therapy for ...
Based on a new study, ketamine may be preferred among outpatients and for those with “moderately severe or severe” depression, whereas ECT may be ...
Ketamine
Mar
19
2025
Ketamine addiction is soaring among teens, so here's everything parents need to know
As shocking new statistics reveal an 85% surge in the use of ketamine, Head of Clinical Care at Delamere, Steph Massey shares her advice for ...
Mar
17
2025
A Modern Overview of the Potential Therapeutic Effects of Psilocybin in the Treatment of ... - Cureus
Psilocybin, a naturally occurring compound found in certain mushroom species, has been used historically in various religious and ceremonial practices ...
Psilocybin
Mar
17
2025
"I was broken": Veteran touts medical benefits of psilocybin at Roundhouse | News | abqjournal.com
SANTA FE — After being injured during combat tours in Iraq and Afghanistan, Chris Peskuski returned to civilian life damaged both physically and ...
Mar
17
2025
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reports Fourth Quarter and Full Year 2024 ...
Initiated filing of a New Drug Application ("NDA") to the FDA for NRX-100 (IV Ketamine) for the treatment of Suicidal Depression; planned filing ...
Mar
17
2025
Psychedelic Mushrooms Market on Course for Notable Expansion, Surpassing US$ 3.3 Bn by 2031
The global psychedelic mushrooms market is on a rapid growth trajectory, with an estimated valuation of US$3.3 billion by the end of 2031, ...
Mar
17
2025
FDA warning about injectable cannabis products (Newsletter: March 17, 2025)
... psychedelics reform; PA medical marijuana patient DUI bill; Study: Cannabis effective for PTSD. Subscribe to receive Marijuana Moment's newsletter ...
Cannabis
Mar
17
2025
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reports Fourth Quarter and Full Year 2024 ...
Initiated filing of a New Drug Application (“NDA”) to the FDA for NRX-100 (IV Ketamine) for the treatment of Suicidal Depression; planned filing ...
Mar
17
2025
Filament Health unveils positive data from Phase 2 alcohol use disorder trial
Filament Health Corp (NEO:FH, OTCQB:FLHLF) announced that its psilocybin drug candidate, PEX010, reduced heavy drinking days by more than 50% in a ...
Mar
17
2025
atai Life Sciences Reports Fourth Quarter and Full Year - GlobeNewswire
... MDMA. Initiated an exploratory Phase 2, randomized, double-blind, placebo-controlled clinical study to assess the safety, tolerability and ...
Mar
11
2025
MDMA May Have Helped October 7 Hamas Attack Survivors Cope With Trauma: Study
Early findings suggest that MDMA especially in its pure form may have provided some psychological protection against trauma to the survivors.
MDMA
Mar
11
2025
ONE Retreats Jamaica Partners with University of Ottawa to Offer Psychedelic Fieldwork and ...
... psilocybin-assisted therapy. This collaboration represents a major ... psilocybin-assisted therapy sessions in a safe, legally regulated ...
Mar
11
2025
PharmaTher Receives US FDA Approval Goal Date for Ketamine - Stock Titan
FDA grants priority review for PharmaTher's ketamine solution targeting critical U.S. supply shortage. Decision expected June 2025 with potential ...
Ketamine
Mar
11
2025
PharmaTher receives FDA approval goal date for ketamine - TipRanks.com
... Letter from the U.S. Food and Drug Administration for its New Drug Application for Ketamine. In the AAL...
Mar
11
2025
PharmaTher Receives US FDA Approval Goal Date for Ketamine - GlobeNewswire
... Ketamine, is pleased to announce today that the Company has received an Amendment Acknowledgement Letter (“AAL”) from the U.S. Food and Drug ...
Ketamine
Mar
11
2025
PharmaTher Receives FDA Approval Goal Date for Ketamine - TipRanks.com
The company has addressed minor deficiencies noted by the FDA and aims to remove Ketamine from the FDA's drug shortage list, which would restrict ...
Ketamine
Mar
11
2025
atai Life Sciences Announces First Patient Dosed in - GlobeNewswire
... (DMT) applied to the buccal surface, in people suffering from treatment ... VLS-01 is a proprietary oral transmucosal film formulation of N,N- ...
Mar
11
2025
PharmaTher Receives New Early June FDA Goal Date for Ketamine - HCPLive
With a new FDA goal date in June, Ketamine is one step closer to receiving approval for anesthesia, sedation, pain, mental health, ...
Ketamine